Chief Executive Officer (since 2023), Caliber Holdings Corporation, a private multi-site operator of auto body collision repair centers (Caliber) Senior Advisor (since 2012), Abingworth LLP, a life sciences venture capital firm Operating Partner (2022 - 2023), Hellman & Friedman, LLC, a private equity firm Chairman and Chief Executive Officer (2012 -2022) PPD, Inc., a global contract pharmaceutical research organization acquired by Themo Fisher Scientific Inc. in 2021 President and General Manager, Emerging Markets and Established Products (2010 - 2012), management roles of increasing responsibility (1996 - 2010), including President and General Manager, Established Products, President, Pharmaceuticals Eastern Europe, Vice President, Marketing Canada, President, Pharmaceuticals Greece, Cyprus and Malta Affiliates, Pfizer Key Skills and Experience: CEO and Public Company Management, Global Business, Healthcare Industry, and Strategy and M&A Experience developed during his various executive roles, giving him significant knowledge and insights regarding the global pharmaceutical industry, drug development and capital markets; along with direct experience with our established products portfolio from his days overseeing that division while at Pfizer Human Capital Management gained as the Chief Executive Officer of Caliber Other Current Private Company Boards: Cordis (since 2022), Director Former Private Company Boards: Launch Therapeutics, Inc. (2022 - 2025), Chairman Curia Global, Inc. (2018 - 2020), Director Medline Industries, Inc. (2022 - 2024), Director Former Public Company Boards: PPD (2012 - 2022 following its acquisition by Thermo Fisher Scientific, Inc.), Chairman Owens & Minor, Inc. (NYSE: OMI) (2013 - 2018), Director Other Organizations: Trustee, David and Melissa Simmons Family Foundation Trustee, The Linsly School